Mandate

Vinge has advised Bilia in connection with the issuance and repurchase of bonds

Vinge has advised Bilia AB (publ) in connection with the issue of new senior and non subordinated bonds with a framework amount of SEK 1 500 000 000 as well as the repurchase of SEK 500 000 000 of a previously issued senior and non subordinated bond with a maturity date in 2021.

Initially, a bond in the amount of SEK 800 000 000 was issued, of which SEK 500 000 000 will be used for the repurchase of the previously issued bond and the remaining amount for repayment of bank loans as well as part financing of Bilia’s acquisitions in Belgium. 

The newly issued bonds have a term of 5 years and are subject to a variable interest of STIBOR 3M + 1.40%. 

Vinge’s team primarily consisted of Anders Strid, Lina André and Henrik Wastenson (tax).
 

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025